Author:
Bitencourt Shanna,Mesquita Fernanda,Basso Bruno,Schmid Júlia,Ferreira Gabriela,Rizzo Lucas,Bauer Moises,Bartrons Ramon,Ventura Francesc,Rosa Jose Luis,Mannaerts Inge,Grunsven Leo Adrianus,Oliveira Jarbas
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference31 articles.
1. Kershenobich Stalnikowitz, D., & Weissbrod, A. B. (2003). Liver fibrosis and inflammation: A review. Annals of hepatology, 2(4), 159–163. PubMed PMID: 15115954.
2. Day, S. A., Lakner, A. M., Moore, C. C., Yen, M. H., Clemens, M. G., Wu, E. S., et al. (2011). Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation. Biochemical Pharmacology, 81(8), 996–1003. PubMed PMID: 21291870. Epub 2011/02/05. eng.
3. Van Beneden, K., Mannaerts, I., Pauwels, M., Van den Branden, C., & van Grunsven, L. A. (2013). HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis & Tissue Repair, 6(1), 1. PubMed PMID: 23281659. Pubmed Central PMCID: 3564760.
4. Iimuro, Y., & Brenner, D. A. (2008). Matrix metalloproteinase gene delivery for liver fibrosis. Pharmaceutical Research, 25(2), 249–258. PubMed PMID: 17577645. Pubmed Central PMCID: 2245995.
5. Solís-Herruzo, J., Solís-Muñoz, P., Muñoz-Yagüe, T., & García-Ruiz, I. (2011). Molecular targets in the design of antifibrotic therapy in chronic liver disease. Revista Espanola de Enfermedades Digestivas, 103(6), 310–323.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献